Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Celltrion is a prominent South Korean biopharmaceutical company primarily focused on the development and production of biosimilars and new drugs. It develops and supplies a diverse range of biosimilar medicines, including Remsima, Truxima, and Herzuma, which are used in the treatment of autoimmune diseases and cancer, to markets worldwide.
셀트리온은 바이오시밀러 및 신약 개발, 생산을 주력으로 하는 대한민국의 대표적인 바이오 제약 기업입니다. 자가면역질환 및 항암 치료에 사용되는 램시마, 트룩시마, 허쥬마 등 다양한 바이오시밀러 의약품을 개발하여 전 세계 시장에 공급하고 있습니다.
Same business group (Fair Trade Act)
Sorted by total assets — with control basis
… +17 more
